+987.9%
MRNA vs MKTX
+5.4%
+982.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MKTX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | 0.0% | +13.1% | +13.1% |
| 7D | +20.6% | +0.5% | +20.2% | +20.5% |
| 30D | +27.1% | +1.0% | +26.2% | +26.9% |
| 3M | +353.4% | +2.5% | +350.9% | +351.2% |
| 6M | +446.3% | +8.0% | +438.2% | +426.7% |
| YTD | +776.2% | -7.3% | +783.4% | +774.8% |
| 1Y | +987.9% | +4.7% | +983.3% | +904.3% |
| All | +987.9% | +5.4% | +982.5% | +904.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MKTX.
Daily Out/Under-Performance
Portfolio return minus MKTX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MKTX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MKTX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling